Table 2.
Long-term survival after curative surgery for esophageal cancer in EP vs. YP.
| Author, Year [Reference] |
EP Definition (Years) |
Disease-Related Survival EP/YP |
Overall Survival EP/YP |
||
|---|---|---|---|---|---|
| Aoyama, 2020 [43] | 75 | 15.1/20.7 * | Median DFS, mo | 16.4/29.8 * | Median (mo) |
| Song, 2020 [58] | 79 | - | - | 18/62 * | Median (mo) |
| Chen, 2019 [44] | 80 | 38.5/40.4 | Median (mo) | ||
| Bakhos, 2019 [65] | 80 | - | - | 23/29.3 * | Median (mo) |
| Kanda, 2019 [45] | 75 | 12/33 | 5-year DFS (%) | 12/35 | 5-year (%) |
| Baranov, 2019 [46] | 75 | - | - | 57.3/54.5 | 2-years (%) |
| Paulus, 2017 [36] | 80 | - | - | 40/62 * | 5-year (%) |
| Miyata, 2015 [49] | 70 | 42/58* | 5-year DFS (%) | 29.3/52.4 * | 5-year (%) |
| Liu, 2015 [50] | 70 | - | 15.8/13.7 | Median (mo) | |
| Morita, 2013 [51] | 80 | 38/40 | 5-year DFS (%) | 10/35 | 5-year (%) |
| Mirza, 2013 [59] | 70 | - | 10.8/15.6 | Median (mo) | |
| Tapias, 2013 [38] | 80 | 49.2/72.4 * | 5-year DSS (%) | 49.2/64.8 * | 5-year (%) |
| Markar, 2013 [52] | 80 | - | 53.2/77.6 | Median (mo) | |
| Cijs, 2010 [29] | 70 | 27/34 * | 5-year DSS (%) | 22/29 * | 5-year (%) |
| Zehetner, 2010 [64] | 80 | 48.9/57.3 | Median, DSS (mo) | 19.7/42.5 * | Median (mo) |
| Elsayed, 2010 [39] | 70 | - | 20/27.6 | Median (mo) | |
| Yang, 2010 [40] | 70 | 24/35.5 | 5-year DFS (%) | 30/41.8 * | 5-year (%) |
| Pultrum, 2010 [41] | 70 | - | 33/33 | 5-year (%) | |
| Davies, 2010 [14] | 70 | - | 20/28 | Median (mo) | |
| Takagawa, 2008 [25] | 75 | 40/46 | Median, DFS (mo) | 22/38 * | Median (mo) |
| Morita, 2008 [57] | 80 | 22/46 | Median, DFS (mo) | 9/39 * | 5-year (%) |
| Ruol, 2007 [30] | 70 | - | 35.4/33.6 | 5-year (%) | |
| Finlayson, 2007 [54] | 80 | - | 17.6/31.4 * | 5-year (%) | |
| Moskovitz, 2006 [32] | 80 | - | 16.8/48 * | Median (mo) | |
| Di Martino, 2005 [55] | 70 | - | 17.8/35.1 | 5-year (%) | |
| Rahamim, 2003 [34] | 70 | - | 13/21 * | 5-year (%) | |
| Sabel, 2002 [18] | 70 | - | 24/27 | Median (mo) | |
| Fang, 2001 [35] | 70 | 55.4/59.1 | 5-year (%), DSS | 40.9/48.1 | 5-year (%) |
| Kinugasa, 2001 [31] | 70 | - | 32.9/35.3 | 5-year (%) | |
| Johansson, 2000 [60] | 70 | - | 24/24 | Median (mo) | |
EP = Elderly patients, YP = Younger patients, DFS = Disease-Free Survival, DSS = Disease-specific survival. Significant p-values < 0.05 are indicated with an asterisk *.